Antiviral Agents
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Antiviral agents are drugs approved by the Food and Drug Administration (FDA) for the treatment or control of viral infections. Available antiviral agents mainly target stages in the viral life cycle. The target stages in the viral life cycle are; viral attachment to host cell, uncoating, synthesis of viral mRNA, translation of mRNA, replication of viral RNA and DNA, maturation of new viral proteins, budding, release of newly synthesized virus, and free virus in body fluids. At least half of available antiviral agents are for the treatment of human immunodeficiency virus (HIV) infections. The others are used mainly for the management of herpesviruses, hepatitis B virus (HBV), hepatitis C virus (HCV), and respiratory viruses. Antiviral agents can be used for prophylaxis, suppression, preemptive therapy, or treatment of overt disease. Two important factors that can limit the utility of antiviral drugs are toxicity and the development of resistance to the antiviral agent by the virus. In addition, host phenotypic behaviors toward antiviral drugs because of either genomic or epigenetic factors could limit the efficacy of an antiviral agent in an individual. This article summarizes the most relevant pharmacologic and clinical properties of current antiviral agents, and targets for novel antiviral agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The FDA did not approve the oral usage of the drug because it induces CYP3A enzyme activity, resulting in a drug interaction, especially with oral contraceptives [101].”
From Viral meningitis: an overview (2021) · cites this paper as [101]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Neuraminidase inhibitors for preventing and treating influenza in healthy adults
Jefferson, T., Jones, M. A., Doshi, P., Del Mar, C. B., Dooley, L., Hama, R., & Heneghan, C. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001265.pub2 · Cited by 226
RetractedAntiviral drugs in current clinical use
De Clercq, E. (2004) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.02.009 · Cited by 947
Recommendations for the management of herpes zoster
Dworkin, R. H., Johnson, R. W., Breuer, J., Gnann, J. W., Levin, M. J., Backonja, M., Betts, R. F., Gershon, A. A., Haanpää, M. L., McKendrick, M. W., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510206 · Cited by 869
New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease
Kleymann, G., Fischer, R., Betz, U. A. K., Hendrix, M., Bender, W., Schneider, U., Handke, G., Eckenberg, P., Hewlett, G., Pevzner, V., et al. (2002) · Nature Medicine · doi:10.1038/nm0402-392 · Cited by 330
The HBV Drug Entecavir — Effects on HIV-1 Replication and Resistance
McMahon, M. A., Jilek, B. L., Brennan, T. P., Shen, L., Zhou, Y., Wind-Rotolo, M., Xing, S., Bhat, S., Hale, B., Hegarty, R., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067710 · Cited by 292
Balfour, H. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904223401608 · Cited by 285
Herpes simplex: Encephalitis children and adolescents
Whitley, R. J., & Kimberlin, D. W. (2005) · Seminars in Pediatric Infectious Diseases · doi:10.1053/j.spid.2004.09.007 · Cited by 219
Enteroviral Meningitis: Natural History and Outcome of Pleconaril Therapy
Desmond, R. A., Accortt, N. A., Talley, L., Villano, S. A., Soong, S.-J., & Whitley, R. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00227-06 · Cited by 154
Antiviral therapy for varicella and herpes zoster
Arvin, A. M. (2002) · Seminars in Pediatric Infectious Diseases · doi:10.1053/spid.2002.29753 · Cited by 76
Current treatment of hepatitis B
Dusheiko, G. M., & Antonakopoulos, N. (2007) · Gut · doi:10.1136/gut.2005.077891 · Cited by 36
Research works printed but not linked: 1
- Whitley, 2000, Antiviral agents, vol. 2
Cited by
Rónavári, A., Igaz, N., Adamecz, D. I., Szerencsés, B., Molnar, C., Kónya, Z., Pfeiffer, I., & Kiricsi, M. (2021) · Molecules · doi:10.3390/molecules26040844 · Cited by 361
Kohil, A., Jemmieh, S., Smatti, M. K., & Yassine, H. M. (2021) · Archives of Virology · doi:10.1007/s00705-020-04891-1 · Cited by 164
Using Wolbachia to Eliminate Dengue: Will the Virus Fight Back?
Edenborough, K. M., Flores, H. A., Simmons, C. P., & Fraser, J. E. (2021) · Journal of Virology · doi:10.1128/jvi.02203-20 · Cited by 57
Antiviral efficacy of cerium oxide nanoparticles
Nefedova, A., Rausalu, K., Žusinaite, E., Vanetsev, A. S., Rosenberg, M., Koppel, K., Lilla, S., Visnapuu, M., Šmits, K., Kisand, V., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-23465-6 · Cited by 46
Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients
Huntjens, D. W., Dijkstra, J. A., Verwiel, L. N., Slijkhuis, M., Elbers, P., Welkers, M. R. A., Veldkamp, A. I., Kuijvenhoven, M. A., de Leeuw, D. C., Abdullah-Koolmees, H., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010163 · Cited by 42
Metadata
- Authors
- Paintsil, E., & Cheng, Y.-C.
- Affiliations
- Yale University (US)
- ORCID
- Paintsil, E.
- Venue
- Encyclopedia of Microbiology
- Publisher
- Elsevier
- Published
- 2009
- Pages
- 223-257
- PMC
- PMC7149689
- OpenAlex
- W4205254504
- Cited by
- 55
- References
- 14
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 11 · 2023: 8 · 2022: 12 · 2021: 11 · 2020: 2
- Type
- reference entry
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Elsevier eBooks (publishedVersion)
- PubMed Central (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Keywords
- antiviral agents, viral life cycle, HIV, herpesvirus, hepatitis B virus, hepatitis C virus, respiratory viruses, antiviral resistance, drug toxicity, prophylaxis, antiviral drug targets, epigenetic factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antiviral Agents. https://app.cochat.ai/papers/10.1016/b978-012373944-5.00178-4
- The paper
- Paintsil, E., & Cheng, Y.-C. (2009). Antiviral Agents. Encyclopedia of Microbiology. https://doi.org/10.1016/b978-012373944-5.00178-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.